Revive Therapeutics Provides Corporate Update
TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a...
Diagnostics
Global Health Intelligence Shares Insights on Medical Equipment Market Leaders in Latin America
GHI provides key insights into Latin America's medical equipment sales leadersMIAMI, FL / ACCESSWIRE / March 11, 2024 / Global...
United States Medical Diagnostics Research Report 2024: Market Impacts of Surging Adoption of Healthcare Wearables and Rising Integration with Artificial Intelligence – Forecasts to 2028 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)"...
Healthy.io and Johns Hopkins Collaborate to Utilize New Patient-Facing Technology to Improve Wound Care Management
The program will work to establish remote monitoring for patients within Johns Hopkins Hospital to improve the outcomes for chronic...
Tom O’Lenic joins RedShiftBio as Chief Executive Officer
Extensive Commercial Expertise and Proven Track Record of Success Tom O'Lenic's appointment marks a strategic move for RedShiftBio amidst rising...
GE HealthCare to Spotlight Industry-Leading AI-Enabled Portfolio and Digital Solutions at HIMSS 2024
Booth (#2500) will showcase AI-enabled innovations and digital solutions that enhance clinical decision making and provide personalized patient careORLANDO, Fla.--(BUSINESS...
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology
Company Continues Expanding its Intellectual Property Footprint, Now has 14 US and 4 International PatentsSANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ:...
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
ANN ARBOR, MI / ACCESSWIRE / March 7, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Spectral AI Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem
DALLAS, March 07, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence...
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
●Q4 and FY Revenue of $10.3 million and $40.2 million; a $8.4 million and 26% increase year-over-year ●Q4 and FY Income...
QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada
Aiding in the diagnosis of preterm pre-eclampsia and prognosis of delivery in symptomatic womenSAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq:QDEL) (“QuidelOrtho”), a...
Phlebotomist’s Actions Keep One Patient Coming Back
NORTHAMPTON, MA / ACCESSWIRE / March 6, 2024 / A patient who goes often to a Patient Service Center (PSC)...
New Swedish Clinical Study Published In The British Journal Of Dermatology Demonstrates Superiority Of AI-Algorithm Guided Melanoma Diagnosis
Dermalyser AI-driven support tool achieved remarkable sensitivity and specificity values of 95% and 85%, respectively, with these figures increasing to...
Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma
Submission supported by data from Phase 3 PERSEUS study, which showed the daratumumab subcutaneous formulation-based regimen significantly reduced the risk...
My Quest Story – Allan Mendez
NORTHAMPTON, MA / ACCESSWIRE / March 5, 2024 / A chance encounter at a previous job put me on the...
LinusBio Named “Fierce 15” Company of 2023 by Fierce Medtech
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--LinusBio, a leader in precision exposome sequencing, today announced its inclusion in Fierce Medtech's "Fierce 15" list...
Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
Company Continues to Build and Expand the Global IP Portfolio of Its One-of-a-Kind TechnologyCHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO),...
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
ANN ARBOR, MI / ACCESSWIRE / March 5, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
• Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans•...
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
Dr. Jay Wohlgemuth, former Chief Medical & Scientific Officer of Quest Diagnostics and Dr. Ray Tabibiazar, a seasoned industry executive,...